Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 86Unknown 54Recruiting 40Terminated 25Not yet recruiting 19Active not recruiting 16Withdrawn 12Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 6Oxaliplatin 5Irinotecan 5Specimen Handling 4S 1 (combination) 4Leucovorin 4Fluorouracil 4Capecitabine 4Radiotherapy 3Nivolumab 3Drug Therapy 3Bevacizumab 3trifluridine tipiracil drug combination 2titanium silicide 2spartalizumab 2lenvatinib 2aldesleukin 2Surgical Procedures, Operative 2Photochemotherapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Immunotherapy 2Endoscopic Mucosal Resection 2Cyclophosphamide 2Cetuximab 2Biopsy 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zimberelimab 1vactosertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Surgical Procedures, Operative × Gastrointestinal × Clear all
NCT06246344 2026-05-01

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Shandong Cancer Hospital and Institute

Suspended
128 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡